Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OKYO compared with CRVO: revenue, margins and what each company keeps, and the suppliers and customers both name
OKYO
OKYO Pharma Ltd
Change
Mkt cap
Revenue
Revenue
CRVO
CervoMed Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OKYO
OKYO Pharma Ltd
vs
CRVO
CervoMed Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OKYO
1
—
On Target Therapeutics
unlisted
supplier
Shared
0
No shared counterparties.
Only CRVO
3
VRTX
Vertex
supplier
—
NIA Grant
unlisted
supplier
—
NIA
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
OKYO
OKYO Pharma Ltd
Change
1.42
▲
+1.07%
· post 1.41
Mkt cap
$75.0M
Revenue
—
Revenue
—
CRVO
CervoMed Inc.
Change
1.41
▼
−2.76%
· post 1.35
Closed
Nov 6 '26
Mkt cap
$21.5M
Revenue
$8,726
Q4 FY25
Revenue
$4M
FY25
vs
Compare
Closed
Nov 6 '26
OKYO
OKYO Pharma Ltd
vs
CRVO
CervoMed Inc.
1.42
▲
+1.07%
post 1.41
Price
1.41
▼
−2.76%
post 1.35
$75.0M
Mkt cap
$21.5M
—
Revenue
$8,726
Q4 FY25
—
Revenue
$4M
FY25
Change
Change
OKYO
1.42
▲
+1.07%
vs
CRVO
1.41
▼
−2.76%
Closed
Nov 6 '26